Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788853 | SCV000928121 | likely pathogenic | not provided | 2018-12-14 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001784401 | SCV002024743 | likely pathogenic | Polycystic liver disease 1 | 2021-10-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001784401 | SCV002811057 | likely pathogenic | Polycystic liver disease 1 | 2024-03-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000788853 | SCV003927304 | likely pathogenic | not provided | 2023-05-22 | criteria provided, single submitter | clinical testing | Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 12529853) |
Genomics And Bioinformatics Analysis Resource, |
RCV001784401 | SCV004024105 | likely pathogenic | Polycystic liver disease 1 | no assertion criteria provided | research |